Berkeley Advanced Biomaterials Status
The company was acquired by GNI USA, a subsidiary of GNI Group (TYO:2160) for $59.7 million on July 31, 2017. The acquisition will help GNI USA to expand its product line.
Producer of calcium-based materials. The company's calcium based materials include hydroxyapatite (HAP), tricalcium phosphate (TCP), calcium sulfate, calcium phosphates, and other products for orthopedic surgery, bone tissue engineering, and life science research applications, enabling customers to get biocompatible phases with morphologies and microstructures that can be tailored to their specific applications.
Year Founded
1996
RevenueFY 2017
$16.2 M
Net IncomeFY 2017
$62.4 K
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Acquired/Merged (Operating Subsidiary)
-
Financing Status
Corporate Backed or Acquired
Berkeley Advanced Biomaterials News and Updates
Hydroxyapatite Market Size, Analysis, Status and Global Outlook 2021 to 2028 – Domestic Violence
Domestic Violence | July 31, 2021
Biomaterials Market Size, Analysis, Status and Global Outlook 2021 to 2028 – Domestic Violence
Domestic Violence | July 31, 2021
Berkeley Advanced Biomaterials's Verticals
Berkeley Advanced Biomaterials Primary Industry Sector / Group / Code
Berkeley Advanced Biomaterials's Trends
Berkeley Advanced Biomaterials Metrics
SimilarWeb Unique Visitors
Majestic Referring Domains
Headquarters
-
HQ Address Line 1901 Grayson Street
-
HQ Address Line 2Suite 101
-
HQ CityBerkeley
-
HQ State/ProvinceCalifornia
-
HQ Post Code94710
-
HQ CountryUnited States
Berkeley Advanced Biomaterials's Keywords
mood_badFeed is empty.
Add a review